Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Shifting funds with limited resources requires thoughtful prioritization. This intro provides practical tips to optimize your remaining dollars.
25,048 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
The IDX framework sits at the center of a pivotal industry debate as market power concentrates and data becomes a str...
U.S. grid operators and policymakers set a 2027 deadline for bitcoin miners to demonstrate they help, not hurt, relia...
Broadcom is moving deeper into AI infrastructure, signaling a shift that could influence chip design, data-center cos...
AI-driven investment has become a major growth engine for the U.S. economy, but a slowdown could ripple across jobs, ...
A rising capital markets wave is lifting expectations for banks, with a forecast of about 25% earnings growth for the...
Cardano ADA surged after cooler US inflation data, with traders eyeing a potential breakout. On‑chain activity and wh...
Abbott Laboratories moved higher after boosting its profit outlook and signaling strength across its diagnostics and ...
As investors eye fastenal (FAST) 2026 earnings, the focus is on demand cycles, margin resilience, and cash flow stren...
XRP has fallen roughly 60% from its July peak and sits near $1.45 as a wave of selling presses lower. Traders eye cri...
Metallus faces a dynamic metals market in 2025. This guide breaks down expected MTUS 2025 earnings, the drivers behin...
National Case-Shiller data shows real price gains disappeared in 2025 as inflation ran hotter than housing, with the ...